2DPA-1 市场规模、份额和成长分析（按应用、最终用途和地区）- 产业预测 2025-2032

2023 年 2DPA-1 市场规模价值为 6,654.4 亿美元，预计将从 2024 年的 6,907.3 亿美元成长到 2032 年的 9,308.6 亿美元，预测期内（2025-2032 年）的复合年增长率为 3.8%。

2DPA-1 的全球市场正在不断增长，这得益于该化合物在製药、农业化学品、染料製造、个人护理等各个领域的广泛应用。 2DPA-1（2-二苯乙酰-1,3-茚满二酮）以其独特的性能而闻名，是许多配方中的关键化学中间体，并因其有益的特性而受到讚誉，例如在护肤产品中的抗衰老和抗氧化特性。各行各业日益增长的需求凸显了寻求利用创新解决方案的市场相关人员的巨大成长潜力。此外，预计美国2DPA-1 市场在未来一年将保持持续的复合年增长率，凸显了这个充满活力的领域的投资和市场发展机会。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析
• 案例研究
• 监管格局
• 专利分析

2DPA-1 市场规模：依应用与复合年增长率（2025-2032）

• 市场概况
• 药品
• 农业化学品
• 化妆品
• 其他的

2DPA-1 市场规模：依最终用途及复合年增长率（2025-2032）

• 市场概况
• 卫生保健
• 纤维和染料
• 其他的

2DPA-1 市场规模：依地区及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Siemens AG（Germany）
• GE Healthcare（United States）
• Philips Healthcare（Netherlands）
• Canon Medical Systems Corporation（Japan）
• Hitachi, Ltd.（Japan）
• Toshiba Medical Systems Corporation（Japan）
• Koninklijke Philips NV（Netherlands）
• Fujifilm Holdings Corporation（Japan）
• Carestream Health, Inc.（United States）
• Esaote SpA（Italy）
• Samsung Medison Co., Ltd.（South Korea）
• Hologic, Inc.（United States）
• Mindray Medical International Limited（China）
• Agfa-Gevaert NV（Belgium）
• Shimadzu Corporation（Japan）
• CurveBeam LLC（United States）
• Planmed Oy（Finland）
• Medtronic plc（Ireland）
• Varian Medical Systems, Inc.（United States）
• Epiroc AB（Sweden）

结论和建议

2DPA-1 Market size was valued at USD 665.44 billion in 2023 and is poised to grow from USD 690.73 billion in 2024 to USD 930.86 billion by 2032, growing at a CAGR of 3.8% during the forecast period (2025-2032).

The global 2DPA-1 market is on the rise, driven by the compound's versatile applications in various sectors, including pharmaceuticals, agrochemicals, dye production, and personal care. Known for its unique properties, 2DPA-1 (2-diphenylacetyl-1,3-indandione) serves as a critical chemical intermediate in many formulations and is praised for its beneficial attributes like anti-aging and antioxidant effects in skincare products. This escalating demand across diverse industries underscores significant growth potential for market players looking to leverage innovative solutions. Furthermore, the US 2DPA-1 market is anticipated to maintain a sustainable CAGR in the coming forecast year, highlighting an opportune moment for investment and development in this dynamic sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the 2DPA-1 market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

2DPA-1 Market Segments Analysis

Global 2DPA-1 Market is segmented by Application, End Use and region. Based on Application, the market is segmented into Pharmaceuticals, Agrochemicals, Cosmetics and Others. Based on End Use, the market is segmented into Healthcare, Textile & Dye and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the 2DPA-1 Market

The pharmaceutical sector is perpetually on the lookout for new and groundbreaking drug candidates to tackle diverse health issues. The distinctive therapeutic attributes of 2DPA-1-encompassing anti-inflammatory, anti-cancer, and antiviral properties-are propelling its utilization in drug discovery and development. This increasing interest and reliance on 2DPA-1 are contributing to a notable cumulative annual growth rate (CAGR) for the global market of 2DPA-1 over the projected timeframe. As the demand for effective treatments escalates, 2DPA-1 stands out as a promising candidate, further stimulating its integration into various therapeutic applications and solidifying its position within the pharmaceutical landscape.

Restraints in the 2DPA-1 Market

The emergence of new entrants in both regional and global markets may enhance competitiveness, potentially jeopardizing the positions of established players. As these newcomers introduce innovative products and diversify their offerings, existing businesses must adapt and refine their strategies to maintain market share. A robust and improved product portfolio from competitors could heighten the stakes, prompting a more aggressive approach to marketing and innovation among current players. This dynamic landscape necessitates that established firms continually assess their value propositions and respond effectively to the challenges posed by fresh market participants, ensuring their sustainability and growth in an increasingly competitive environment.

Market Trends of the 2DPA-1 Market

The 2DPA-1 market is currently facing a trend characterized by its intricate and costly production processes, which impede its broader adoption across industries. As manufacturers grapple with high production costs, the economic viability of 2DPA-1 becomes a significant concern, potentially limiting its accessibility and affordability. This financial barrier could hinder market expansion, resulting in a relatively modest compound annual growth rate (CAGR) throughout the forecast period. Despite its potential applications, the complexity of 2DPA-1 manufacturing may deter widespread usage, making it essential for industry players to innovate and streamline production techniques to boost market growth.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Patent Analysis

Global 2DPA-1 Market Size by Application & CAGR (2025-2032)

• Market Overview
• Pharmaceuticals
• Agrochemicals
• Cosmetics
• Others

Global 2DPA-1 Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Healthcare
• Textile & Dye
• Others

Global 2DPA-1 Market Size & CAGR (2025-2032)

• North America (Application, End Use)
  • US
  • Canada
• Europe (Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Siemens AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hitachi, Ltd. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Toshiba Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Koninklijke Philips N.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Fujifilm Holdings Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Carestream Health, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Esaote SpA (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Medical International Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agfa-Gevaert NV (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shimadzu Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CurveBeam LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Planmed Oy (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Varian Medical Systems, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Epiroc AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations